Obesity changes your muscle 'engine type': Excess weight shifts muscle fiber composition, reducing efficient, fat-burning Type I fibers and increasing less efficient, fatigue-prone Type IIx fibers, worsening metabolic flexibility
Market impact and costs Global GLP-1 sales exceeded $41B in 2024 and are expected to triple by 2030, according to industry reports
On the basis of these findings, a clinical study program was started to investigate the efficacy and safety of tirzepatide in the treatment of obesity and obesity management
These products are carefully formulated to address a variety of skincare needs
Acetaminophen 500-1,000 mg every 4-6 hours (max 3,000 mg/day in standard adults) is an acceptable alternative when NSAIDs are contraindicated, but note the hepatotoxicity interaction addressed below